Weiguang Biology: Announcement on the application for issuance of shares to specific objects has been reviewed and approved by the Listing Review Center of the Shenzhen Stock Exchange
Securities code: 002880 Securities abbreviation: Weiguang Biology Announcement number: 2026-012
Shenzhen Weiguang Biological Products Co., Ltd.
Regarding the application for issuance of stocks to specific objects, the Shenzhen Stock Exchange
Announcement of approval by the Listing Review Center
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
Shenzhen Weiguang Biological Products Co., Ltd. (hereinafter referred to as the company) will be launched in April 2026 On March 9, the Shenzhen Stock Exchange (hereinafter referred to as the Shenzhen Stock Exchange) received the "Notification of the Opinions of the Review Center on Shenzhen Weiguang Biological Products Co., Ltd.'s Application for Issuing Stocks to Specific Objects" issued by the Listing Review Center. The Issuance and Listing Review Agency of the Shenzhen Stock Exchange reviewed the company's application documents for issuance of shares to specific objects and concluded that the company meets the issuance conditions, listing conditions and information disclosure requirements. Subsequently, the Shenzhen Stock Exchange will report to the China Securities Regulatory Commission (hereinafter referred to as the China Securities Regulatory Commission) in accordance with regulations to perform relevant registration procedures.
The company's issuance of shares to specific objects still needs to be approved and registered by the China Securities Regulatory Commission before it can be implemented. There is uncertainty about whether the final decision on whether to obtain the approval of the China Securities Regulatory Commission for registration and the time required for registration. The company will perform its information disclosure obligations in a timely manner based on the progress of the matter. Investors are advised to make prudent decisions and pay attention to investment risks.
Board of Directors of Shenzhen Weiguang Biological Products Co., Ltd.
April 10, 2026